Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-03-12 2:52 pm Purchase | 2026-01-30 | 13G | Coya Therapeutics, Inc. COYA | Dr. Reddy's Laboratories, Inc. | 2,272,727 9.700% | 2,272,727![]() (New Position) | Filing History |
| 2026-01-30 1:28 pm Purchase | 2025-12-31 | 13G | Coya Therapeutics, Inc. COYA | The Vanguard Group | 899,140 4.290% | 899,140![]() (New Position) | Filing History |
| 2026-01-28 2:13 pm Sale | 2025-12-31 | 13G | Coya Therapeutics, Inc. COYA | HIRSCHMAN ORIN | 1,108,171 5.300% | -225,748![]() (-16.92%) | Filing History |
| 2025-02-14 4:26 pm Purchase | 2024-12-31 | 13G | Coya Therapeutics, Inc. COYA | DME Capital Management LP | 1,651,440 9.900% | 1,651,440![]() (New Position) | Filing History |
| 2025-02-10 08:35 am Purchase | 2024-12-31 | 13G | Coya Therapeutics, Inc. COYA | HIRSCHMAN ORIN | 1,333,919 8.000% | 1,333,919![]() (New Position) | Filing History |
| 2024-11-12 3:37 pm Unchanged | 2024-11-12 | 13G | Coya Therapeutics, Inc. COYA | The Vanguard Group | 0 0.000% | 0 (Unchanged) | Filing |
| 2024-11-04 1:27 pm Unchanged | 2024-11-04 | 13G | Coya Therapeutics, Inc. COYA | The Vanguard Group | 0 0.000% | 0 (Unchanged) | Filing |
| 2024-11-04 11:42 am Unchanged | 2024-11-04 | 13G | Coya Therapeutics, Inc. COYA | The Vanguard Group | 0 0.000% | 0 (Unchanged) | Filing |
| 2024-02-14 4:46 pm Unchanged | 2024-02-14 | 13G | Coya Therapeutics, Inc. COYA | GREENLIGHT CAPITAL INC | 0 0.000% | 0 (Unchanged) | Filing |
| 2024-02-07 6:55 pm Unchanged | 2024-02-07 | 13G | Coya Therapeutics, Inc. COYA | HIRSCHMAN ORIN | 0 0.000% | 0 (Unchanged) | Filing |
| 2023-12-12 4:05 pm Unchanged | 2023-12-12 | 13G | Coya Therapeutics, Inc. COYA | GREENLIGHT CAPITAL INC | 0 0.000% | 0 (Unchanged) | Filing |
| 2023-02-14 4:36 pm Unchanged | 2023-02-14 | 13G | Coya Therapeutics, Inc. COYA | Berman Howard | 0 0.000% | 0 (Unchanged) | Filing |
| 2023-02-14 4:06 pm Unchanged | 2023-02-14 | 13G | Coya Therapeutics, Inc. COYA | Berman Howard | 0 0.000% | 0 (Unchanged) | Filing |
| 2023-01-05 08:30 am Unchanged | 2023-01-05 | 13G | Coya Therapeutics, Inc. COYA | HIRSCHMAN ORIN | 0 0.000% | 0 (Unchanged) | Filing |

